Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Top Growth Stocks to Buy With $500


When investing in equities, even a relatively modest initial sum such as $500 can go a long way, provided investors pick the right stocks and continue adding to their positions regularly. Let's address the first part of this equation: Picking the right stocks. With myriads of options to choose from, it's not always an easy thing to do.

Here are two companies to consider: Sarepta Therapeutics (NASDAQ: SRPT) and Shopify (NYSE: SHOP). These two growth stocks are worth holding onto for five or more years. Here is why.

Sarepta Therapeutics is a biotech company that focuses on developing medicines for rare diseases. The company has four approved products, all of which treat Duchenne muscular dystrophy (DMD) -- a progressive genetic illness that leads to muscle degeneration and an extremely shortened lifespan. Sarepta Therapeutics' portfolio of DMD therapies is generating consistently growing sales. In the second quarter, the company's revenue rose by about 12% year over year to $261.2 million.

Continue reading


Source Fool.com

Sarepta Therapeutics Stock

€120.85
-0.740%
Sarepta Therapeutics shows a slight decrease today, losing -€0.900 (-0.740%) compared to yesterday.
The community is currently still undecided about Sarepta Therapeutics with 1 Buy predictions and 0 Sell predictions.
With a target price of 130 € there is a slightly positive potential of 7.57% for Sarepta Therapeutics compared to the current price of 120.85 €.
Like: 0
Share

Comments